Tullio Sulser
Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Müller J, von Schulthess G, Kaufmann P, Kranzbuehler H, John H, Zilli T, Müller A, Omlin A, Schmid D, Sulser T, Kroeze S, Guckenberger M, Eberli D, Kedzia S, Garcia Schüler H, Muehlematter U, Ferraro D, Burger I. Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction. Eur J Nucl Med Mol Imaging 2018
28.11.2018Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
28.11.2018Eur J Nucl Med Mol Imaging 2018
Müller Julian, von Schulthess Gustav K, Kaufmann Philipp A, Kranzbuehler Helmut, John Hubert, Zilli Thomas, Müller Alexander, Omlin Aurelius, Schmid Daniel M, Sulser Tullio, Kroeze Stephanie G C, Guckenberger Matthias, Eberli Daniel, Kedzia Sarah, Garcia Schüler Helena I, Muehlematter Urs J, Ferraro Daniela A, Burger Irene A
Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
Fankhauser C, Moch H, Sulser T, Poyet C, Hermanns T, Rueschoff J, Rupp N, Omlin A, Gillessen Sommer S, Schüffler P, Wild P. Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. Oncotarget 2017; 9:10284-10293.
04.12.2017Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
04.12.2017Oncotarget 2017; 9:10284-10293
Fankhauser Christian D, Moch Holger, Sulser Tullio, Poyet Cédric, Hermanns Thomas, Rueschoff Jan H, Rupp Niels J, Omlin Aurelius, Gillessen Sommer Silke, Schüffler Peter J, Wild Peter J
Multidisciplinary care in patients with prostate cancer: room for improvement
Strebel R, Winterhalder R, Morant R, Pless M, Huber U, Fehr M, Gillessen Sommer S, Schmid H, Sulser T, Cathomas R. Multidisciplinary care in patients with prostate cancer: room for improvement. Support Care Cancer 2013; 21:2327-33.
26.03.2013Multidisciplinary care in patients with prostate cancer: room for improvement
26.03.2013Support Care Cancer 2013; 21:2327-33
Strebel Räto T, Winterhalder Ralph, Morant Rudolf, Pless Miklos, Huber Urs, Fehr Martin, Gillessen Sommer Silke, Schmid Hans-Peter, Sulser Tullio, Cathomas Richard
Relevance of periostin splice variants in renal cell carcinoma
Morra L, Moch H, Schraml P, Kristiansen G, Sulser T, Diener P, Santimaria R, Duc Luu V, Casagrande S, Rechsteiner M, Soltermann A. Relevance of periostin splice variants in renal cell carcinoma. Am J Pathol 2011; 179:1513-21.
18.07.2011Relevance of periostin splice variants in renal cell carcinoma
18.07.2011Am J Pathol 2011; 179:1513-21
Morra Laura, Moch Holger, Schraml Peter, Kristiansen Glen, Sulser Tullio, Diener Pierre-André, Santimaria Roger, Duc Luu Van, Casagrande Silvia, Rechsteiner Markus, Soltermann Alex
High incidence of independent second malignancies after non-muscle-invasive bladder cancer
Zecha H, Schmid H, Tschopp A, Sulser T, Engeler D. High incidence of independent second malignancies after non-muscle-invasive bladder cancer. Scand J Urol Nephrol 2011; 45:245-50.
28.03.2011High incidence of independent second malignancies after non-muscle-invasive bladder cancer
28.03.2011Scand J Urol Nephrol 2011; 45:245-50
Zecha Henrik, Schmid Hans-Peter, Tschopp Alois, Sulser Tullio, Engeler Daniel
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
Savic S, Casella R, Zellweger T, Forster T, Sulser T, Gasser T, Schönegg R, Spieler P, Dalquen P, Eichenberger T, Mattarelli G, Lehmann K, Schmauss M, Engeler D, Thalmann G, Zlobec I, Bubendorf L. The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. International journal of cancer. Journal international du cancer 2009; 124:2899-904.
15.06.2009The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
15.06.2009International journal of cancer. Journal international du cancer 2009; 124:2899-904
Savic Spasenija, Casella Roberto, Zellweger Tobias, Forster Thomas, Sulser Tullio, Gasser Thomas C, Schönegg René, Spieler Peter, Dalquen Peter, Eichenberger Tobias, Mattarelli Gianfranco, Lehmann Kurt, Schmauss Martina, Engeler Daniel, Thalmann George N, Zlobec Inti, Bubendorf Lukas
Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation
Stolzmann P, Scheffel H, Rentsch K, Schertler T, Frauenfelder T, Leschka S, Sulser T, Marincek B, Alkadhi H. Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urol Res 2008; 36:133-8.
01.08.2008Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation
01.08.2008Urol Res 2008; 36:133-8
Stolzmann Paul, Scheffel Hans, Rentsch Katharina, Schertler Thomas, Frauenfelder Thomas, Leschka Sebastian, Sulser Tullio, Marincek Borut, Alkadhi Hatem
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer
Zellweger T, Benz G, Cathomas G, Mihatsch M, Sulser T, Gasser T, Bubendorf L. Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer 2006; 119:1660-5.
01.10.2006Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer
01.10.2006Int J Cancer 2006; 119:1660-5
Zellweger Tobias, Benz Gabriel, Cathomas Gieri, Mihatsch Michael J, Sulser Tullio, Gasser Thomas C, Bubendorf Lukas